Structure-based design of new potent and highly selective PARP-1 inhibitor for treating colorectal cancer
{{output}}
Poly (ADP-ribose) polymerase 1 (PARP-1) exhibits high expression levels in colorectal cancer (CRC) patients and participates in multiple DNA damage repair pathways, thereby emerging as an attractive target. Herein, we identified a series of PARP-1 inhibitors (... ...
